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Background: Exposure to ionizing radiation (IR) results in the simultaneous activation or downregulation of multiple
signaling pathways that play critical roles in cell type-specific control of survival or death. IR is a well-known genotoxic
agent and human carcinogen that induces cellular damage through direct and indirect mechanisms. However,
its impact on epigenetic mechanisms has not been elucidated, and more specifically, little information is available
regarding genome-wide DNA methylation changes in cancer cells after IR exposure. Recently, genome-wide DNA
methylation profiling technology using the Illumina HumanMethylation450K platform has emerged that allows
us to query >450,000 loci within the genome. This improved technology is capable of identifying genome-wide
DNA methylation changes in CpG islands and other CpG island-associated regions.
Results: In this study, we employed this technology to test the hypothesis that exposure to IR not only induces
differential DNA methylation patterns at a genome-wide level, but also results in locus- and gene-specific DNA
methylation changes. We screened for differential DNA methylation changes in colorectal cancer cells after IR
exposure with 2 and 5 Gy. Twenty-nine genes showed radiation-induced hypomethylation in colon cancer cells,
and of those, seven genes showed a corresponding increase in gene expression by reverse transcriptase polymerase
chain reaction (RT-PCR). In addition, we performed chromatin immunoprecipitation (ChIP) to confirm that the
DNA-methyltransferase 1 (DNMT1) level associated with the promoter regions of these genes correlated with their
methylation level and gene expression changes. Finally, we used a gene ontology (GO) database to show that a
handful of hypomethylated genes induced by IR are associated with a variety of biological pathways related to cancer.
Conclusion: We identified alterations in global DNA methylation patterns and hypomethylation at specific cancer-
related genes following IR exposure, which suggests that radiation exposure plays a critical role in conferring epigenetic
alterations in cancer.
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Colon cancerBackground
Epigenetics is defined as heritable changes in gene
expression that are not accompanied by changes in
DNA sequences [1]. Epigenetic mechanisms are essential
for the maintenance of tissue-specific gene expression
patterns, and they are required for normal mammalian
development. Disregulation of epigenetic processes can
lead to altered gene function and malignant cellular
transformation, and global changes in the epigenetic
landscape are a hallmark of cancer.* Correspondence: jmyi@diram.re.kr
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unless otherwise stated.Epigenetics is becoming more widely investigated in
the field of cancer biology. Epigenetic regulation of gene
expression is mediated primarily through DNA methyla-
tion, microRNAs (miRNAs), and histone modifications,
such as acetylation, methylation, phosphorylation, and
ubiquitination. DNA methylation is perhaps the most
extensively studied epigenetic modification in mammals.
Generally, there are two types of alterations that can
occur in the DNA methylation patterns in cancer at both
locus-specific and genome-wide levels: hypomethylation
and hypermethylation [2]. In the field of cancer epigen-
etics, most research has focused on the role and clinical
relevance of the hypermethylation of tumor suppressor
gene promoters [3]. However, there have been far feweris is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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global DNA hypomethylation is a well-known characteris-
tic of cancer cells. This hypomethylation is specifically
enriched in mobile genetic elements, such as long inter-
spersed element 1 (LINE1) and Alu elements. [4].
Unlike genetic alterations, epigenetic alterations are often
reversible, which makes elucidating the mechanisms of epi-
genetic regulation extremely attractive from the perspective
of developing new therapeutic approaches. The reversible
nature of epigenetic aberrations has led to the emergence
of the promising field of epigenetic therapy.
Ionizing radiation (IR) is a potentially lethal threat to all
organisms, but it is also an efficient and valuable treatment
option in cancer therapy [5]. Radiation therapy triggers
a complex, multi-pathway cellular response that usually
results in the death of cancer cells. Although IR is a
well-known genotoxic agent and human carcinogen that
induces cellular damage through direct and indirect
mechanisms [6], its impact on epigenetic mechanisms has
not been elucidated.
Our previous study suggested that the combination of
IR and the demethylating agent 5-aza--2′-deoxycytidine
(5-aza-dC) could be an effective treatment strategy for
colon cancer [7]. These data also prompted us to explore
the potential molecular alterations responsible for the
biological effects observed after treatment with IR and
5-aza-dC. In rodents, IR can affect global DNA methyla-
tion and cause significant and persistent DNA hypome-
thylation in radiation target genes, and in human cells, IR
can cause genome instability [8]. However, there has been
a lack of studies on the effects of IR on locus- and gene-
specific DNA methylation. Several groups have performed
gene expression profiling to understand how IR affects
radiosensitive cancer cells at the molecular level [9,10].
Other studies have shown that treatment with 5-aza-dC to
reduce global DNA methylation has a radiosensitizing
effect, suggesting that DNA methylation plays a role in
radiation resistance [11,12]. However, little information
is available regarding DNA methylation changes at the
genome-wide level in cancer cells after IR exposure.
Genome-wide DNA methylation profiling technology
using the Illumina HumanMethylation450K array allows
us to query >450,000 loci within the genome and to cover
99% of RefSeq genes [13]. This improved technology can
provide a more powerful and comprehensive analysis of
DNA methylation changes. In this study, we employed this
technology to test the hypothesis that exposure to IR not
only induces differential DNA methylation patterns at a
genome-wide level, but also affects methylation at a locus-
and gene-specific level. We screened for differential DNA
methylation changes in colorectal cancer cells after IR
exposure with 2 and 5 Gy. We identified global DNA
methylation changes and gene-specific hypomethylation at
bona fide target genes that were induced by IR exposure.Results
IR induces global DNA methylation changes in colon
cancer cells
We previously demonstrated that pretreatment with the
DNA methyltransferase inhibitor 5-aza-dC sensitizes colon
cancer cells to IR. More specifically, we showed that the
level of apoptosis is greater when the cells are treated with
a combination of 5-aza-dC and IR than when they are
treated with either agent alone, suggesting that the com-
bination of 5-aza-dC and IR is a potential strategy for the
treatment of cancer [7]. These data led us to explore
whether IR exposure induces DNA methylation changes
at both the genome-wide level and the locus- or gene-
specific levels in colon cancer.
To determine the DNA methylation changes that occur
after IR exposure in colon cancer, we chose HCT116 colo-
rectal cancer cells as a model, because we had shown in a
previous study that 5-aza-dC treatment enhances the sen-
sitivity of HCT116 cells to IR. In this study, HCT116 cells
were exposed to 2 different IR doses, 2 or 5 Gy, which are
known to not induce a high rate of apoptosis with a single
treatment. We also treated HCT116 cells with 5-aza-dC
(0.5 μM), which served as an internal control for estimat-
ing the global demethylation levels.
First, we determined whether IR treatment of HCT116
cells affected the expression of well-known regulators of
DNA methylation, such as DNA-methyltransferase 1
(DNMT1), methyl-CpG binding domain proteins 2 and
4 (MBD2 and MBD4), and methyl CpG binding protein
2 (MeCP2). Reverse transcriptase polymerase chain reac-
tion (RT-PCR) analyses revealed that these factors were
only slightly altered by radiation treatment at the mRNA
level (Figure 1A). However, western blot analyses showed
that the protein levels of DNMT1 and 3b were decreased
in cells exposed to IR (5 Gy) or 5-aza-dC, suggesting that
there could be global DNA methylation changes caused
by IR treatment (Figure 1B).
To determine genome-wide DNA methylation changes,
we performed DNA methylation profiling. HCT116 cells
were irradiated at 2 or 5 Gy, or treated with 5-aza-dC
for 72 hrs. Next, the isolated DNA was subjected to
genome-wide level DNA methylation profiling using
the Illumina HumanMethylation450K BeadChip. The
irradiated and 5-aza-dC-treated samples were compared
to mock-treated samples to determine regions of differen-
tial DNA methylation.
The probe call rate was >99% for all of the samples
and 454,215 CpG sites out of 485,577 were included in
the analysis. To identify hypermethylated loci, we looked
for probes or genes that had Δβ-values > I1.5I fold for
IR- or 5-aza-dC-treated cells vs. control cells. Interest-
ingly, there were no probes or genes showing hypermethy-
lation in irradiated cells. To identify hypomethylated loci,
we set the Δβ-values <1.5 fold for IR- or 5-aza-dC-treated
Figure 1 Ionizing radiation alters the levels of epigenetic regulators in HCT116 cells. (A) RT-PCR was performed to show the mRNA levels
of methylation regulatory factors (DNMT1, MBD2, MBD4, and MeCP2) in HCT116 cells irradiated with 2 or 5 Gy, or treated with 5-aza-dC as a
control. (B) Western blots show the protein expression levels of DNMT1 and DNMT3b in HCT116 cells irradiated with 2 or 5 Gy, or treated
with 5-aza-dC as a control. The blots were probed using anti-DNMT1 (upper panel) and anti-DNMT3b (middle panel) antibodies. GAPDH and
anti-β-actin were used for normalization for RT-PCR and western blotting analyses, respectively.
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were hypomethylated by IR at similar levels to those
observed in 5-aza-dC-treated cells (Figure 2). These data
validated reports from previous studies that showed
that radiation is linked to global hypomethylation in
the genome [8,14,15].
Identification of radiation-induced hypomethylation in
colon cancer cells
Next, we focused on the identification of radiation-
induced hypomethylated genes or loci in HCT116 cells.
We applied a strict filter to identify the hypomethylated
candidate genes induced by radiation at 2 or 5 Gy, or by
5-aza-dC treatment (Δβ-values <1.5 fold compared with
mock-treated cells) (Additional file 1: Figure S1). After
we excluded non-reliable probes based on Δβ-values in
control (mock treated) dataset, we normalized the DNA
methylation data by comparing the mock-treated cells
with the 5-aza-dC- or IR-treated cells (Additional file 1:
Figure S1). In particular, 5-aza-dC, a strong inducer of
DNA de-methylation (global hypomethylation), is, an
analogue of cytosine, that when incorporated into DNA,
irreversibly binds the methyltransferase enzymes as they
attempt to methylate the cytosine analogue. This deple-
tion of methyltransferase in the cell results in passive
de-methylation, which is known to reactivate epigeneti-
cally silenced genes [16]. Therefore, the dataset from the
5-aza-dC-treated cells was a necessary control to help
identify the candidate genes that were hypomethylated
by radiation. With our criteria (Δβ-values < I1.5I fold),
we detected 4,675, 89, and 71 probes in 5-aza-dC-treated
cells, 2 Gy-irradiated cells, and 5 Gy-irradiated cells,respectively (Figure 2A). Comparing with irradiated cells
and 5-aza-dC, indeed, 25 probes were identified from
the 2 Gy-irradiated dataset, and 21 probes were identi-
fied from the 5 Gy-irradiated dataset, and probes related
29 candiate genes were identified by comparing with
the 5-aza-dC-treated dataset (Figure 2A and Additional
file 1: Figure S1). Using heatmap analysis of these probes,
we observed the differences in the DNA methylation
levels between control cells and 5-aza-dC- or IR-treated
cells (Figure 2B, C). We believe that these final candidate
genes are truly hypomethylated by radiation.
Radiation-induced hypomethylated genes show a
corresponding increase in gene expression in colon
cancer cells
Next, we examined the actual methylation levels of the 29
radiation-induced hypomethylated candidate genes that
were identified from our discovery platform (Table 1). In
terms of the Δβ-values retrieved from the methylation
profile data, most of these genes showed a 1.5- to 11-fold
decrease in DNA methylation in the irradiated cells com-
pared with the control cells (Additional file 1: Figure S2).
Using 29 candidate genes, we next move on to validate
whether gene expression level by RT-PCR of these genes
are correlated with their DNA hypomethylation. We real-
ized that CXADRP2 is a pseudogene and both TSPY1 and
TSPY4 gene have very high (94%) sequence similarity so
that we could not analyze specific their gene expression,
therefore, three genes were excepted from our qRT-PCR
analysis.
It is well known that DNA methylation changes can
alter the transcriptional expression level of genes. To
Figure 2 (See legend on next page.)
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Figure 2 Identification of radiation-induced hypomethylated candidate genes. (A) The Venn diagram shows the number of genes displaying
differential DNA methylation between 5-aza-dC-treated cells and irradiated cells (2 and 5 Gy). The number of common differentially methylated genes
is shown in (i), (ii), and (iii). These common genes were 1.5-fold down-methylated in both 5-aza-dC-treated cells and irradiated cells (2 or 5 Gy). The
table shows a summary of candidate genes, which are indicated as (i), (ii), and (iii) (B, C) The DNA methylation changes for the indicated cells treated
with 5-aza-dC (x-axis) or IR (2 or 5 Gy; y-axis) are plotted by log-fold change, and individual probes are shown in black. Red dots indicate candidate
probes that are down-methylated by both 5-aza-dC and IR (2 or 5 Gy) (left panels). Heatmap analysis shows the final candidate genes indicated by red
dots in the scatter plots (right panels) and displays the decreasing methylation levels of the 5-aza-dC- and IR-treated groups compared with controls
(mock). The color gradient from green to red displays the β-value and ranges from 0 (unmethylated) to 1 (methylated).
Table 1 Information of target genes
Gene Accession No. Function
ANGPT1 NM_001146.3; NM_001199859.1; NM_139290.1 Angiopoietin 1
APBB2
NM_001166050.1; NM_001166051.1; NM_001166052.1;
NM_001166053.1; NM_001166054.1; NM_004307.1; NM_173075.4




ATP Synthase, H+ Transporting, Mitochondrial F1 Complex,
Alpha Subunit 1, Cardiac Muscle




Fragile Site, Folic Acid Type, Rare, Fra(10)(Q23.3)




Cancer Susceptibility Candidate 1
CHGA NM_001275.3 Chromogranin A (Parathyroid Secretory Protein 1)
CTGF NM_001901.2 Connective Tissue Growth Factor
CXADRP2 NR_024387 Coxsackie Virus And Adenovirus Receptor Pseudogene 2
HAUS1 NM_138443.3 HAUS Augmin-Like Complex, Subunit 1
IFI16 NM_001206567.1; NM_005531.2 Interferon, Gamma-Inducible Protein 16
IGLON5 NM_001101372.1 IgLON Family Member 5
LBR NM_002296.3; NM_194442.2 Lamin B Receptor
LMAN1 NM_005570.3 Lectin, Mannose-Binding, 1
LYRM5 NM_001001660.2 LYR Motif Containing 5
MCOLN1 NM_020533.2 Mucolipin 1
MTMR8 NM_017677.3 Myotubularin Related Protein 8
PDZRN3 NM_015009.1 PDZ Domain Containing Ring Finger 3
PLCL2 NM_001144382.1; NM_015184.5 Phospholipase C-Like 2
PLEKHM2 NM_015164.2
Pleckstrin Homology Domain Containing,
Family M (With RUN Domain) Member 2
RASAL1 NM_001193520.1; NM_001193521.1; NM_004658.2 RAS Protein Activator Like 1 (GAP1 Like)
SLC43A2 NM_001284498.1; NM_001284499.1; NM_152346.2 Solute Carrier Family 43, Member 2
SP1 NM_001251825.1; NM_003109.1; NM_138473.2 Sp1 Transcription Factor
TCERG1L NM_174937.3 Transcription Elongation Regulator 1-Like
TSPY1 NM_001197242.1; NM_003308.3 Testis Specific Protein, Y-Linked 1
TSPY4 NM_001164471.1 Testis Specific Protein, Y-Linked 4
ZNF175 NM_007147.2 Zinc Finger Protein 175
ZNF69 NM_021915.2 Zinc Finger Protein 69
ZSWIM5 NM_020883.1 Zinc Finger, SWIM-Type Containing 5
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Figure 3 Correlation between DNA hypomethylation and gene expression of candidate genes. (A) Seven genes (ANGPT1, APBB2, CHGA,
CTGF, IFI16, IGLON5, and SLC43A2) showed a correlation between their levels of DNA hypomethylation and gene expression. The methylation fold-change
values were obtained from the HumanMethylation450K profile, and the gene expression fold-change values were quantified by qRT-PCR from
HCT116 cells with either 5-aza-dC treatment (0.5 μM) or IR (2 or 5 Gy). The bar graphs indicate the gene expression level, and the line charts
indicate the methylation level. (B) Quantitative MSP (qMSP) analysis of the CpG island of the APBB2, CHGA, and CTGF gene are shown. The promoter
region (defined as upstream and downstream 1 kb from the transcriptional start site; TSS) includes typical CpG islands. The MSP primer location is
indicated with a red bar. Each bar graph indicates the DNA methylation level of the APBB2, CHGA, and CTGF gene by qMSP, respectively. The candidate
gene methylation values were normalized to the methylation of an Alu element. *P < 0.05; ***P < 0.001.
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irradiated and 5-aza-dC-treated cells caused transcriptional
gene expression changes, we measured the mRNA expres-
sion level of these genes by quantitative RT-PCR (qRT-
PCR) analysis. We plotted the gene expression changes
with the methylation changes to determine whether the
level of demethylation or hypomethylation at each gene
corresponded with the level of increased gene expression.
Importantly, seven genes (ANGPT1, APBB2, CHGA, CTGF,
IFI6, IGLON5, and SLC43A2) showed the expected correl-
ation between demethylation or hypomethylation by 5-
aza-dC or radiation treatments, and increased mRNA
expression levels (Figure 3A). Therefore, we identified
seven radiation-induced hypomethylated genes with
increased gene expression in colon cancer cells.
To verify the methylation status of these genes, we used
methylation-specific PCR (MSP) analysis. We tested three
(APBB2, CHGA, and CTGF) genes out of the seven genes
as a representative example. As shown in Figure 3B, we
confirmed the methylation status of the CpG islands
around the APBB2 , CHGA, and CTGF by quantitative
methylation-specific PCR (qMSP). These data confirmed
that the these genes are strong candidate hypomethylated
genes by IR.
Radiation-induced hypomethylated genes show
decreased levels of DNMT1 in their promoter regions
As shown in Figure 1, DNMT1 and 3b are downregulated
in irradiated cells. DNMTs are enzymes that are involved
in a critical step of the DNA methylation process [17]. In
cancer cells, DNMT1 is responsible for the majority of the
DNA-methylation capacity [18,19], and it is a contributing
factor in maintaining the abnormal promoter methylation
in tumor cells. Therefore, we asked whether these genes
might be directly associated with DNMT1 protein in terms
of occurring demethylation after irradiation. Using chroma-
tin immunoprecipitation (ChIP) analysis, we examined the
correlation between DNMT1 and the CpG island located
in the promoter region of each candidate gene in HCT116
cells (Figure 4). We observed that DNMT1 levels were
decreased in the promoter regions of most of the candidate
genes (ANGPT1, APBB2, CHGA, CTGF, IFI6, IGLON5, and
SLC43A2). Among the candidate genes, DNMT1 levels
were decreased from 21 to 50% by 5-aza-dC treatment,from 50 to 81% by 2 Gy IR treatment, and from 48 to 81%
by 5 Gy IR treatment compared with controls. For the
IFI16 gene, we observed there is no correlation between
DNMT1 level of its promoter region and its gene expres-
sion level along with DNA hypomethylation level. These
data strongly support a correlation between decreased
DNMT1 levels and DNA hypomethylation in the promoter
regions of the candidate genes with elevated gene expres-
sion (Figure 4). Taken together, our validation strategy
solidifies the potential biological relevance of these
newly identified genes that are hypomethylated by radi-
ation in colon cancer cells. These findings suggest novel
epigenetic roles for these previously uncharacterized genes
in colon cancer.
Although we identified a handful of genes that were
hypomethylated following irradiation, we wanted to deter-
mine whether these genes are associated with a particular
cellular pathway or network. We analyzed our candidate
gene list using well-curated databases (GO, GeneMANIA
and KEGG) that include a variety of biological processes,
molecular functions, and cellular components (Additional
file 1: Figure S3). The possible roles of the candidate
genes can be hypothesized by looking at the various sig-
naling pathways predicted by KEGG pathway analysis
(Additional file 2: Table S2). Collectively, these data sug-
gested that the radiation-induced hypomethylated genes
play important roles not only in response to radiation, but
also in cellular regulatory events.
Discussion
DNA methylation plays a crucial role in the regulation of
gene expression and chromatin organization within nor-
mal eukaryotic cells. In cancer, global patterns of DNA
methylation are altered. Tumor cells often show global hy-
pomethylation of repeat elements and hypermethylation
of promoter regions of tumor suppressor genes or a subset
of CpG-dense gene-associated regions (CpG islands).
We previously showed that 5-aza-dC pretreatment in-
creases the radiosensitivity of colon cancer cells, and that
the combination of 5-aza-dC treatment and IR promotes
apoptosis, suggesting that this combination treatment
could be useful for clinical applications [7]. Based on this
previous work, we proposed to examine the DNA methy-
lation level of each gene or loci in the genome that could
Figure 4 (See legend on next page.)
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Figure 4 The interactions of DNMT1 with the promoter regions of candidate genes following IR treatment. Chromatin immunoprecipitation
(ChIP) assays were performed to determine the levels of DNMT1 at the promoter regions of candidate genes (ANGPT1, APBB2, CHGA, CTGF, IFI16, IGLON5,
and SLC43A2) in HCT116 cells following 0.5 μM 5-aza-dC treatment or irradiation (2 or 5 Gy). GAPDH was used as negative control. Cross-linked and sheared
chromatin was immunoprecipitated with an anti-IgG antibody (dark gray bar) or with anti-DNMT1 (light gray bar). The results are shown as a percentage
of the input chromatin. Associated chromatin in the ChIP samples were quantified by real-time RT-PCR. The data represents the mean ± the standard
deviation of triplicates. Representative data are shown from three independent trials. *P < 0.05; **P < 0.01; ***P < 0.001; TSS, Transcription Start Site.
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is also important for determining the proper use of demeth-
ylation agents as radiotherapy sensitizers or chemothera-
peutics. Therefore, here, we performed genome-wide DNA
methylation analysis of colon cancer cells after treatment
with 5-aza-dC or IR to examine the DNA methylation
alterations, and we showed that IR treatment of cancer cells
resulted in extensive changes in the DNA methylation sta-
tus of genes.
Other possible mechanism for radiation-induced global
demethylation is the relocalization of DNMTs from the
nucleus to the cytoplasm [20], which may cause a change
in the DNA methylation maintenance machinery in the
genome. In addition, it is possible that radiation promotes
the enzymatic replacement of 5-methylcytosine with cyto-
sine [21].
Although the mechanisms underlying this radiosensiti-
zation effect are not well understood, several studies
have shown that radiation induces global hypomethyla-
tion in human cancers, as evidenced by the depleted ex-
pression levels of DNMT1, MBP proteins, and MeCP2
[22-24]. Here, we have focused on identification of radi-
ation induced hypomethylated genes in colon cancer
cells. Using genome-wide DNA methylation array, we
have demonstrated the radiation effect on global genome
or specific gene as a model system to provide evidence
for radiation induced hypomethylation.
Previously, several tumor- and proliferation-associated
genes were found to be hypomethylated in human cancers.
For example, the pS2 gene, which encodes a pleotropic
factor implicated in the control of cell proliferation, shows
cancer-associated hypomethylation and the concordant
changes in gene expression [25]. In addition, radiation
induces hypomethylation and expression of urinary-type
plasminogen activator (uPA) in meningioma, which could
contribute to meningioma progression in vitro and in vivo
[22]. However, there is still little information on radiation-
induced hypomethylation of specific genes in cancer. In
the present study, we showed radiation-induced hypome-
thylation in colon cancer cells, and we identified several
hypomethylated genes that also showed upregulated gene
expression and downregulated DNMT1 levels in their
promoter regions.
It has been known that radiation has been shown to
induce global hypomethylation [20]. In terms of losing
DNA methylation level at globally, decreased genomicDNA methylation was observed at 24–72 hrs post-
irradiation in cell lines and this could be due to decreased
levels of DNA methyltrasferases (DNMTs). Although
several previous reports have done to see the genomic
hypomethylation with irradiation after different time points
and showed global hypomethylation with different profiles
without specific loci or genes [26], we limited one time
point (72 hrs after 2Gy and 5Gy irradiation) and interest-
ingly we have indeed reached to identification of purely IR
induced hypomethylated genes along with global hypome-
thylation at the genome level.
To date, DNA methylation profiling to determine re-
sponses to ionizing radiation has not been well described.
Kim et al. performed DNA methylation profiling to com-
pare a radioresistant lung cancer cell line to a radiosensitive
lung cancer cell line using Illumina BeadChip to query
27,578 CpG sites [27]. They found 1,091 genes that were
differentially methylated. However, they did not show that
the differentially methylated genes were functionally associ-
ated with the radiosensitive phenotype. More recently,
Antwih et al. identified DNA methylation changes induced
by IR using the HumanMethylation450K array platform in
breast cancer cell line [24]. They suggested that that the dif-
ferentially methylated genes were associated with cellular
processes, such as cell cycle, DNA repair, and apoptosis
pathways. Although similar approach applied to this study
with our work, this study differs from our work in terms of
identification of radiation induced hypomethylated genes.
In our strick criteria, we did not see any genes are hyper-
metylated by IR, therefore we could focused on radiation
induced hypoemthyaltion and the fact is that actual our
candidate genes are hypomethylated (demethylated) in not
only in irradiated cells but also 5-aza-dC treated cells as
well as downregulated their gene expression by RT-PCR in
both, which Specfically, while this work demonstrated that
rdadiation may induce DNA methylation changes and iden-
tify the loci-specific changeds in DNA methylation as we
do here, the expereimetnal for validation for target genes
was not designed to show if these gene expression are regu-
lated by DNA methylation by IR. In our study, genome-
wide DNA methylation array was useful to identify new
genes are induced hypemethylation of them by IR and we
can stress here that these genes were newly identified genes
are hypomethylated by IR with specific validation by several
experimental tools such as qRT-PCR to confirm the correl-
ation between DNA methylation and gene expression and
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transcriptional level by ChIP assaye transcriptional level.
Since this study did not use 5-aza-dC treated cells.
IR exposure results in the simultaneous activation or
downregulation of multiple signaling pathways that play
critical roles in cell type-specific control of survival or
death. Although IR is a well-known genotoxic agent and
human carcinogen [6], very recent studies have sug-
gested that epigenetic mechanisms that are associated
with gene silencing, such as histone modifications and
DNA methylation, may be involved in regulating radio-
sensitivity in cancer cells. A number of previous studies
have reported that several histone deacetylase inhibitors
are cytotoxic and can sensitize tumor cells to radiother-
apy. However, little information is available regarding the
effects of DNMT inhibitors on radiosensitization [12,28].
Our previous work demonstrated that global DNA me-
thylation changes, especially demethylation by 5-aza-dC,
could be important for radiosensitization. We showed that
the combination of 5-aza-dC and IR treatment results in
the apoptosis of colon cancer cells, suggesting that this
combination could be a novel cancer treatment. In this
study, we further demonstrated that radiation induces hy-
pomethylation of site-specific genes in colon cancer cells.
We searched the literature to identify the biological
functions of our bona fide radiation-induced hypomethy-
lated genes. The amyloid beta A4 precursor protein-
binding, family B, member 2 (APBB2) gene encodes a
protein that binds to amyloid beta precursor protein
(APP), which is central to the pathogenesis of Alzheimer’s
disease [29]. In addition, overexpression of APBB2 in
PC12 cells inhibits cell cycle progression through its
nuclear translocation and inhibition of thymidilate syn-
thase, which ultimately leads to a cell cycle delay [30]. Its
role in cell cycle regulation could also be related to the
role of APBB2 in neurodegeneration. Chromogranin A
(CHGA) regulates catecholamine storage and release
through intracellular and extracellular mechanisms [31].
CHGA is also a candidate gene that contributes to auto-
nomic dysfunction syndromes, including the intermediate
phenotypes that contribute to hypertension [31]. Chga-null
mice show abnormal changes in the autonomic control of
circulation, further suggesting a role for CHGA in hyper-
tension risk [32]. Connective tissue growth factor (CTGF)
is also known as insulin-like growth factor-binding protein
8 (IGFBP8). There is little information regarding the
biological function of the CTGF gene in cancer. However,
a polymorphism in the promoter of the CTGF gene,
accompanied by its transcriptional repression, is associ-
ated with susceptibility to systemic sclerosis [33]. In
addition, Nakanish et al. showed that the CTGF gene may
be involved in bone and testis development using trans-
genic Ctgf-overexpressing mice [34]. L-type amino acid
transporter 4 (LAT4, also known as SLC43A2) mediatesthe sodium-independent transport of bulky neutral amino
acids across cell membranes [35]. Taken together, we have
identified genes of unknown function in radiosensitivity
that are hypomethylated in response to radiation and
show corresponding alterations in DNMT1 association
and gene expression in colon cancer cells.
Conclusion
In summary, we have analyzed the genome–wide CpG
methylation profiles of HCT116 cells to identify IR induced
DNA methylation changes. We found that IR induces
DNA hypomethylation, rather than hypermethylation, at
the genome-wide level by comparing with the DNA methy-
lation profiles of 5-aza-dC treated cells. Among these DNA
methylation changes, we found bona fide site-specific genes
that were hypomethylated by IR. Furthermore, these genes
showed increased gene expression and decreased levels of
DNMT1 in their promoter regions that correlated with
their degree of hypomethylation. Therefore, these data
strongly suggest that radiation exposure plays a critical role
in regulating epigenetic alterations in human cancer.
Methods
Cell culture and 5-Aza-dC treatment
The human colorectal carcinoma cell line HCT116 was
obtained from ATCC and cultured in McCoy’s 5A medium
(WelGENE) with 10% fetal bovine serum (Hyclone) and
1% penicillin/streptomycin (Gibco) at 37°C in a humid
incubator with 5% CO2. The cells were treated with
0.5 μM 5-aza-dC (Sigma) for 3 days, replacing media
and 5-aza-dC every 24 hrs.
Irradiation
The cells were exposed to gamma rays through the air-
center mode after changing to fresh media. All irradia-
tions were performed using a 137Cs-ray source (Eckert &
Ziegler) at a dose rate of 2.6 Gy/min. Following irradi-
ation at doses of 2 and 5 Gy, the cells were incubated
for 3 days at 37°C in a humid incubator with 5% CO2.
Methylation array
The Infinium HumanMethylation450K BeadChip (Illu-
mina) includes 485,577 CpG sites located throughout
the genome [36]. Genomic DNA from HCT116 cells
[mock, irradiated (2 and 5 Gy), and 5-aza-dC (0.5 μM
for 72 hrs) treated] was isolated using a phenol/chloro-
form method. Bisulfite modification of genomic DNA
was performed using an EZ DNA Methylation Kit
(Zymo Research). The bisulfite conversion efficiency was
determined by sample-dependent controls on the chip and
was displayed in the quality control panel in the software.
All samples passed quality control measurements. The
samples were run on an Infinium HumanMethylation450K
BeadChip (Illumina) and scanned on an Illumina iScan
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The methylation values for individual CpG sites in each
sample were obtained as β-values. The β-value generated
for each CpG locus measure the intensity of methylated
(β = 1) and unmethylated probes (β = 0). The β-value is a
continuous variable that is calculated by dividing the in-
tensity of the methylated beads by the combined intensity,
and these values range from 0 to 1. A CpG locus was con-
sidered differentially methylated if the β-value was > = |0.2|
and its ratio was > |1.5|X fold compared to control (mock
treated). This cut-off value of |0.2| represents the 99%
confidence interval of the detection limit [13].Hierarchical clustering
>I1.5I fold demethylated (hypomethylated) probes were
independently analyzed in control (mock treated) vs. 5-
aza-dC treated cells, control vs. 2 Gy irradiated cells or
control vs. 5 Gy irradiated cells. The selected probes
were 4,675, 89 and 71 probes, respectively. Commonly
hypoemthylaed probes were collected between control
vs. 5-aza-dC treated cells and control vs. 2 Gy irradiated
cells, or between and control vs. 5 Gy irradiated cells via
Venn diagram analysis, and finally common hypomethy-
lated probes (25 and 21 probes, respectively) were ana-
lyzed. Hierarchical clustering was performed with Agilent
GeneSpring GX 7.3 software using common hypomethy-
lated probes. Pearson Correlation was used for similarity
measurement.Western blotting
Western blotting was performed as described previously
[37]. The antibodies used for western blot analysis were
anti-DNMT1 (Sigma), anti-DNMT3a (Sigma), and anti-
β-actin (Sigma).cDNA synthesis and quantitative RT-PCR
The cells were trypsinized and homogenized using a
QIAshredder Kit (QIAGEN). Total RNA from the cells
was extracted using RNeasy Mini Kit (QIAGEN). The
RNA quantity was measured using a NanoDrop 2000/
2000c instrument (Thermo Scientific). For cDNA syn-
thesis, 1 μg of total mRNA was reverse-transcribed into
cDNA using the iScriptTM cDNA Synthesis Kit (BioRad).
The reaction was performed at 25°C for 5 min and then
42°C for 30 min, and was terminated by heating to 85°C
for 5 min.
The target gene transcripts were analyzed by qRT-PCR,
which was performed using a CFX96TM Real-Time PCR
Detection System (BioRad). All primers were designed
using the Primer3 program (http://bioinfo.ut.ee/primer3/)
and are listed in the Additional file 2: Table S1. For
normalization, human GAPDH was amplified.Bisulfite modification and quantitative methylation-
specific PCR (qMSP)
Genomic DNA was isolated from HCT116 cells using a
phenol/chloroform method. Bisulfite modification of
2 μg of genomic DNA was performed using an EZ DNA
Methylation Kit (Zymo Research). For positive and nega-
tive controls, in vitro methylated DNA (IVD) and H2O
were treated, respectively. For methylation analysis of
target genes, qMSP amplification was performed on
bisulfite-treated samples and normalized by an Alu
element. All primers were designed using MethPrimer
(http://www.urogene.org/cgi-bin/methprimer/methprimer.
cgi) and are presented in Additional file 2: Table S1. qRT-
PCR was performed with a CFX96TM Real-Time PCR De-
tection System (BioRad).Chromatin immunoprecipitation (ChIP)
ChIP assays were performed as previously described
[38]. PCR was performed using a C1000 Thermal Cycler
(BioRad) with the ChIP primers that are listed in Additional
file 2: Table S1. An anti-DNMT1 antibody (Sigma) was
used to immunoprecipitate the DNMT1-associated chro-
matin fragments.Ethics statement
Human colorectal carcinoma cell line HCT116 used in
this study is publically available through ATCC.Additional files
Additional file 1: Figure S1. Overview of the screening approach using
the HumanMethylation450K platform that was performed in this study.
Figure S2. Screen validation by assessing the correlation between gene
expression and methylation levels of the candidate genes identified from
the HumanMethylation450K platform. We assessed the gene expression
level of the 26 hypomethylated genes that were identified from the
methylation using RT-PCR to determine if there was a correlation between
their gene expression and methylation levels. The bar graphs indicate their
gene expression level and the line charts indicate their methylation level.
Figure S3. Gene network analysis of candidate genes visualized by
Cytoscape. The gene interaction analysis, excluding CXADRP2 (pseudogene),
was performed using GeneMANIA and visualized by the Cytoscape 3.0.2
program. The black circles indicate candidate genes and the gray circles
represent interacting genes. CASC1 and LYRM5 failed to show any interactions.
Of the gene interactions, there were six types of evidence codes, each
indicated with a different color node: co-expression (40.92%), physical
interactions (35.98%), pathway (12.29%) co-localization (7.3%), shared
protein domains (1.79%), and genetic interactions (1.73%). Most of the
genes were intimately connected and showed strong interrelationships.
The predicted cellular functions, GO terms, and related genes for each
category, are presented in the table (lower panel). These functional
predictions are statistically significant, and the q-value of the categories
range from 8.02 × 10−2 to 3.10 × 10−6.
Additional file 2: Table S1. Primer information for experiments.
Table S2. Signaling pathway of target genes by KEGG database.Competing interests
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